Influence of contrast-enhanced CT and MRI with or without SPIO particles on therapy and therapy costs for patients with focal liver disease;Einfluss von biphasischer spiral-CT, nativer und eisenoxidverstarkter MRT auf therapie und therapiekosten bei patienten mit fokalen leberlasionen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 172, Issue 3, 2000, Pages 251-259

  Helmberger, Thomas ^a   Gregor, M ^a   Holzknecht, N ^a   Rau, H ^b   Scheidler, J ^a   Reiser, M ^a  

^a Institut für Klinische Chemie Großhadern   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Contrast enhanced spiral CT; Diagnostic efficacy; Ferumoxide; Liver lesions; MR imaging

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER ADENOMA; LIVER DISEASE; LIVER HEMANGIOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADENOMA, LIVER CELL; BIOPSY; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034120262     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hamm B. Kosten-Nutzen-Überlegungen zur modernen Schnittbilddiagnostik am Beispiel der Oberbauchorgane. Radiologe 1996; 36: 292-299
2. Mima S, Sekiya C, Kanagawa H, Kohyama H, Gotoh K, Mizuo H, Ijiri M, Tanabe T, Maeda N, Okuda K. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 1994; 9: 361-365
3. Wolf KJ, Taupitz M, Hamm B. Diagnostik fokaler Leberbefunde. Die Wertigkeit von bildgebenden Systemen. Fortschr Med 1991; 109: 601-605
4. Semelka RC, Schlund JF, Molina PL, Willms AB, Kahlenberg M, Mauro MA, Weeks SM, Cance WG. Malignant Liver Lesions: Comparison of Spiral CT Arteriel Portography and MR Imaging for Diagnostic Accuracy, Cost, and Effect on Patient Management. JMRI 1996; 1: 39-43
5. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP, Pringot J, Mathieu D, Bruel JM. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-792
6. Bonsel GJ, Klompmaker IJ, Essink-Bot ML, Habbema JD, Slooff MJ. Cost-effectiveness analysis of the Dutch liver transplantation programme. Transplant Proc 1990; 22: 1481-1484
7. Evens RG. Diagnostic imaging in cancer care. The role of cost/ benefit analysis. Cancer 1991; 67: 1245-1252
8. Baker ME. What is the most cost-effective imaging workup for hepatic hemangiomas, and is it safe to obtain a biopsy of such a suspected hemangioma? Am J Roentgenol 1994; 163: 1261
9. Biggs CG, Ballantyne GH. Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994:94-102
10. Black WC, Beam CA, Camaratta J, HanleyJ, Malenka D, Sugarman M, Thornbury JR, Wagner RF. Report from Efficacy Subgroup MR Methodology Workshop. JMRI 1996; 1: 1-3
11. Gerhardt P. Diagnostische Radiologie im Spektrum der Kostenentwicklung in der Medizin. Radiologe 1996; 36: 270-278
12. Golder W. Nutzen, Kosten und Analytik in der diagnostischen Radiologie: Definition und Glossar. Fortschr Röntgenstr 1999; 170: 73-79
13. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11: 88-94
14. Lin HH, Lin DY. Is preoperative ultrasound cancer survey necessary in patients with normal liver function tests? J Clin Gastroenterol 1991; 13: 108-110
15. Romano G, Esercizio L, Santangelo M, Vallone G, Santangelo ML. Impact of computed tomography vs. intrarectal ultrasound on the diagnosis, resectability, and prognosis of locally recurrent rectal cancer. Dis Colon Rectum 1993; 36: 261-265
16. Born M, Layer G, Kreft B, Schwarz N, Schild H. MRT, CT, CTAP in der Diagnostik maligner Lebertumoren bei Leberzirrhose. Fortschr Röntgenstr 1998; 168: 567
17. Bartolozzi C, Caramella D, Lencioni R, Bassi AM, Moretti M, Armillotta N, del Sarto M. Cost-effectiveness of intrainstitutional information exchange in the diagnostic and therapeutic management of hepatocellular carcinoma. Acad Radiol 1996; 3: S7-S9
18. Müller RD, Vogel K, Neumann K, Hirche H, Barkhausen J, Stoblen F, Henrich H, Langer R. MRT mit superparamagnetischen Eisenpartikeln versus Doppelspiral-CT beim Nachweis maligner Leberläsionen. Fortschr Röntgenstr 1998; 168: 436-443
19. Pawluk RS, Tummala S, Brown JJ, Borello JA. A retrospective analysis of the accuracy of T2-weighted images and dynamic Gadolinium-enhanced sequences in the detection and characterization of focal hepatic lesions. JMRI 1999; 9: 266-273
20. Kang JY, Lee TP, Yap I, Lun KC. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers. J Gastroenterol Hepatol 1992; 7: 463-468
21. Parker RG. The "cost-effectiveness" of radiology and radiologists. Radiology 1993; 189: 363-369
22. Mackenzie R, Dixon AK. Measuring the effects of imaging: An evaluative framework. Clin Radiol 1995; 50: 513-518
23. van Kaick G, Reiser M. Kosten-Nutzenanalyse in der Radiologie (Editorial). Radiologe 1996; 36: 269
24. Neuberger J, Bryan S. Clinical economics review: cost-effectiveness in the therapy of liver disease. Aliment Pharmacol Ther 1997; 11: 61-68
25. Hoffmann V, Richter GM, Funk H, Otto G, Kauffmann GW. Lebertransplantation und diagnostische Radiologie: sozioökonomische Aspekte. Fortschr Röntgenstr 1996; 165: 113-117
26. Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657-663
27. Strotzer M, Gmeinwieser J, Schmidt J, Fellner C, Seitz J, Albrich H, Zirngibl H, Feuerbach S. Diagnosis of liver metastasis from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997; 38: 986-992